Alaska Medicaid Pharmacy - Naloxone: point-of-sale edits and prior authorization
Customize your policy alerts
Sign up for all Alaska Medicaid policy alerts
Know when Alaska Medicaid releases new policies or updates existing guidance.
Monitor payer policy activity
Defines Alaska Medicaid pharmacy claims processing edits and prior authorization requirements for naloxone products, and pharmacist actions when multiple Narcan® Nasal Spray fills occur; applies to Alaska Medicaid-enrolled beneficiaries and dispensing pharmacists.
Prior authorization requirement for Narcan® Nasal Spray (NS) was removed except in specific circumstances.
A point-of-sale edit will reject claims for a patient's third Narcan® NS fill within a rolling 365-day period and requires pharmacist prescriber contact and documentation before override.
Evzio® Auto-Injector requires step therapy prior authorization before payment will be considered.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.